Oncology

CVS Caremark is expanding into the realm of specialty oncology management for drugs covered under the medical benefit and traditionally administered in physician offices or clinics.

Pharmacies in the community setting have led the way in patient compliance, but have been largely ignored by MCOs and the pharmaceutical industry.

Instructing patients to take oral anticancer medications without food is a costly, risky move, says pharmacology specialist.

The comprehensive management of oncolytic therapy is only possible with the emergence of oncology pharmacy vendors within a unique distribution channel.

Diplomat Specialty Pharmacy's president and chief executive officer shares his thoughts about the turbulent oncology arena and how specialty pharmacists can survive the storm and prosper.

A closer look at payer management in oncology reveals trends for both oncologists and payers in this changing environment as health plans continue to seek methods to curtail costs associated with cancer care.

Here's an up-to-date review of the oncology therapeutic class, as today's specialty pharmacies need to learn the landscape from all perspectives.

Many of the answers to this question and more lie ahead in this inaugural Specialty Pharmacy Times Oncology Special Issue.

Intravenous bisphosphonates, often used to treat metastases and bone pain in breast cancer patients, are now being used by clinicians for osteoporosis in these patients—pharmacists need to recommend appropriate screening and treatment.